Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - iCoreConnect Inc. | Financial_Report.xls |
| 10-Q - iCoreConnect Inc. | imedicor10q123111.htm |
| EX-32 - iCoreConnect Inc. | ex32.htm |
| EX-31.2 - iCoreConnect Inc. | ex31-2.htm |
Exhibit 31.1
CERTIFICATION
I, Fred Zolla, certify that:
1. I have reviewed this quarterly report on Form 10-Q of iMedicor, Inc;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods presented in this report;
4. The small business issuer's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the small business issuer and have:
a. designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
b. evaluated the effectiveness of the registrant’s disclosure controls and procedures as of the end of the period (the “Evaluation Date”); and
c. presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;
5. The small business issuer's other certifying officer and I have disclosed, based on our most recent evaluation, of internal control over financial reporting, to the small business issuer's auditors and the audit committee of the small business issuer's board of directors (or persons performing the equivalent functions):
a. all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuer's ability to record, process, summarize and report financial information; and
b. any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuer's internal control over financial reporting.
6. The registrant’s other certifying officer and I have indicated in this quarterly report whether there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.
|
iMedicor, Inc.
(Registrant)
|
|||
|
Date: March 9, 2012
|
By:
|
/s/ Fred Zolla
|
|
|
Fred Zolla
|
|||
|
President and Chief Executive Officer
|
|||
|
(Principal Executive Officer)
|
|||